Predictive Multimodal MRI Factors in Subacute Cerebral Artery Occlusiontreated by Thrombectomy (PIMISUTT)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorPoitiers University Hospital
About this trial
Our study aims to measure metabolic and functional parameters of the infarcted territory by multimodal cerebral MRI in patients diagnosed with unilateral proximal occlusion of the middle cerebral artery and treated by thrombectomy in order to correlate those parameters to clinical outcome (evaluated by modified Rankin score) at 3 months.
We aim to find early radiologic predictive factors for favorable clinical outcome in this population of patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged ≥ 18 years old
Hospitalized at the Poitiers University Hospital
Acute middle cerebral artery occlusion diagnosed by CT-scan or MRI
NIHSS score ≥ 6 at admission
Disqualifiers
Patients or relatives whom a loyal information about the study cannot be given
Patient with cognitive impairments before MRI.
Patients who cannot undergo MRI because of contraindications
Patients too deteriorated to tolerate one hour long exam
Trial design
Design model
Single group
Treatments tested in this trial
Multimodal MRI
Other interventionMultimodal MRI will be realized between 12 and 24 hours after thrombectomy
Treatment groups
50 Participants
are divided into 1 treatment groupGroup A: Multimodal MRIExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Correlation between modified Rankin score at 3 months and multimodal MRI data
Time frame
Month 3Secondary outcomes
1
Discharge National Institute of Health Stroke Score (NIHSS)
Time frame
Month 32
National Institute of Health Stroke (NIHSS) score at 3 months
Time frame
Month 33
Change in NIHSS score at 3 months compared to post-thrombectomy
Time frame
Month 3Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov